FDA.reportPublic FDA data

Minivelle 0.1 MG/Day Twice Weekly Transdermal System

RxCUI
1357009
RxNorm name
Minivelle 0.1 MG/Day Twice Weekly Transdermal System
Display name
Minivelle 0.1 MG/Day Twice Weekly Transdermal System
Full name
Minivelle 0.1 MG/Day Twice Weekly Transdermal System
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MinivelleESTRADIOLNoven Therapeutics, LLC6c5c47ab-28ee-11e1-bfc2-0800200c9a662026-07-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1357009

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6c5c47ab-28ee-11e1-bfc2-0800200c9a66Minivelle 0.1 MG/Day Twice Weekly Transdermal System [PSN] · 84 HR estradiol 0.00417 MG/HR Transdermal System [Minivelle] [SBD] · 84 HR Minivelle 0.00417 MG/HR Transdermal System [SY] · Minivelle 0.1 MG per 24HR Twice Weekly Transdermal Patch [SY] · Minivelle 0.1 MG/Day Twice Weekly Transdermal System [SY]519These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222